Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary ...

Under Bayman's leadership, K&S's group of litigation practices has grown to 550 lawyers or almost half of the firm’s 1,300 ...

ZEISS Medical Technology and Boehringer Ingelheim continue to advance their research collaboration to champion data-driven ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment ...

Novus Diagnostics, an innovator in the field of rapid point-of-care diagnostics, announces the appointment of Dr. Margrit ...

Clarivate Plc , a leading global provider of transformative intelligence, today announced the launch of DRG Commercial Analytics 360?a solution designed to empower medtech companies with advanced ...

The "Enterprise Tech Ecosystem Series: Boehringer Ingelheim 2025" company profile has been added to ResearchAndMarkets.com's offering. Boehringer Ingelheim International: Leading the Way in ...

Suanfarma, a global company specializing in the development, production, and commercialization of active pharmaceutical ...

Christian Boehringer to hand over as Chairman of the Shareholders’ Committee to Hubertus von Baumbach Shashank Deshpande, Member of the Board of ...